Does Rimonabant Independently Affect Free Fatty Acid and Glucose Metabolism? | Zendy

Jessica Triay | Zendy; Manpreet S. Mundi | Zendy; Samuel Klein | Zendy; Frederico G. S. Toledo | Zendy; Steven R. Smith | Zendy; Haitham S. Abu-Lebdeh | Zendy; Michael D. Jensen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Does Rimonabant Independently Affect Free Fatty Acid and Glucose Metabolism?

Author(s) -

Jessica Triay,

Manpreet S. Mundi,

Samuel Klein,

Frederico G. S. Toledo,

Steven R. Smith,

Haitham S. Abu-Lebdeh,

Michael D. Jensen

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-2486

Subject(s) - rimonabant , endocrinology , medicine , placebo , insulin resistance , weight loss , insulin , glucose clamp technique , type 2 diabetes , carbohydrate metabolism , glucose uptake , diabetes mellitus , antagonist , obesity , pancreatic hormone , receptor , cannabinoid receptor , pathology , alternative medicine

Endocannabinoid receptor 1 blockade is proposed to improve metabolic complications of obesity via central and peripheral effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research